Stock BGXX BRIGHT GREEN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Bright Green Corporation

Equities

BGXX

US10920G1004

End-of-day quote Nasdaq
Other stock markets
 18:00:00 2024-06-24 EDT 		5-day change 1st Jan Change
0.32 USD +8.11% Intraday chart for Bright Green Corporation +15.82% -3.06%
06-10 Bright Green Insider Sold Shares Worth $359,700, According to a Recent SEC Filing MT
05-20 Bright Green Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bright Green Insider Sold Shares Worth $359,700, According to a Recent SEC Filing
MT
GRANTS, NEW MEXICO, May 30, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) - Form 8-K
PU
CEO UPDATE
AQ
Bright Green Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Bright Green Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
AQ
Bright Green Corporation Announces Its Expansion Continues with A $100 Million Solar Power Generation Field to Supply the Heat and Electricity to Its Drug Production and Manufacturing Facility
CI
Bright Green Shares Soar on $250 Million Expansion of Drug Production Facility in New Mexico
MT
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
AQ
Bright Green Corporation Announces Plans for $250 Million Expansion of Its Controlled Substances Drug Production Facility in Grants, New Mexico
CI
Bright Green Corporation Enters into a Credit Agreement
CI
Bright Green Corporation Announces Board Changes
CI
Bright Green Corporation (BGXX) submits for historic DEA Registration for Production of Schedule I and Schedule II controlled substances.
AQ
BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS
AQ
Bright Green Corporation Receives Final Approval from the New MexicoBoard of Pharmacy and the DEA
CI
BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS
AQ
Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.
AQ
(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer
AQ
Bright Green Corporation Appoints Groovy Singh as Chief Executive Officer
CI
'Born into horrors' - Gaza newborns suffer in war
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BGXX Stock
  4. News Bright Green Corporation